Leonardo Campos1, Kelley M. Swanberg1, and Christoph Juchem1,2
1Biomedical Engineering, Columbia University, New York, NY, United States, 2Radiology, Columbia University, New York, NY, United States
Synopsis
Keywords: Data Processing, Spectroscopy
There remains controversy
surrounding the use of zero filling during spectral quantification of in vivo
proton magnetic resonance spectra (
1H-MRS) using linear combination model (LCM)
fitting. We examine the potential mixing of real and imaginary information
theorized with zero filling, and whether this is demonstrated by a comparable
change in accuracy and precision provided by complex fitting. We show that
application of zero filling does improve fitting precision when a baseline is
not present; with an imperfectly modeled unknown in vivo baseline, however,
zero filling does not necessarily reduce error in real relative to complex fits.
Purpose
Spectral quantification of 1H-MR spectra commonly involves
linear combination modeling (LCM) of the real spectrum1-6.
Previously, we demonstrated that the application of complex fitting, in which
both the real and imaginary spectra are fit in parallel, consistently improves metabolite
quantification precision and even accuracy7.
Some may argue, however, whether the application of zero filling can recuperate
the differences in accuracy and precision provided by complex fitting. It is
theorized that with the application of zero filling, the real and imaginary
information become Hilbert pairs, allowing for full complex information in the
real spectrum alone8. However, contradictory information is present
regarding whether to apply zero filling during quantification1,9,10.
Here we systematically examine differences in spectral quantification errors
between real and complex fitting across zero-filling conditions. This allows us
to determine whether information exchange occurs when zero filling the real
spectrum, and whether that is comparable to the accuracy and precision provided
by complex fitting. Methods
Previously simulated Lorentzian singlets, metabolite spectra,
and metabolite spectra with in vivo baselines,7 were further
processed to systematically compare LCM real and complex fitting with varying
levels of applied zero filling. This was conducted using INSPECTOR11
with batch functionality12,13. For all analyses, the corresponding simulated
noiseless basis set used for simulating the spectra was also used for fitting.
All 9000 (500 spectra x 9 SNRs x 2 previously defined noise
correlations7) previously simulated Lorentzian singlets were
analyzed for each of 9 zero-filling conditions (Figure 1A). Fit optimization
solely consisted of amplitude scaling (Figure 1C).
Similarly, all 6000 (500 spectra x 6 SNRs x 2 noise correlations) previously
simulated in vivo-like metabolite spectra (MARSS14, 3 T, sLASER15,
TE = 20.1 ms, 2048 complex points, 19 metabolites
with physiologic T2 and concentration7), were
analyzed at 7 zero-filling conditions (Figure 1B). Fit optimization included metabolite-specific
amplitude scaling, Lorentzian broadening and frequency shift, as well as global
zero-order phase and baseline offset (Figure 1C).
Finally, all previously developed spectra with baselines, consisting of
noiseless simulated metabolite spectra combined with measured prefrontal and
occipital cortex macromolecule baselines (20 total)16 using
previously described methods13,17, were analyzed at 6 zero-filling
conditions (Figure 1B). As before7, the basis spectra and fit
optimization employed additional Gaussian shapes in the basis set and a cubic
spline baseline (1-ppm knot interval, no smoothing) to account for
macromolecules and baseline shape respectively (Figure 1C).
Percent error for metabolite estimations was determined relative to perfect (no
residual), noiseless, no-baseline fits. Statistical tests (R version 4.1.218)
involved ANOVAs, post-hoc Tukey's test, and F-tests for the equality of
variances for analysis of average and standard deviation of percent error. All post-hoc
comparisons were corrected using the Benjamini-Hochberg method for the total
number of pairs within that analysis’ zero-filling condition. Results
For singlets without zero filling, real fitting has a
consistently higher standard deviation of percent error by a factor of
approximately √2 (Figure 2A). As zero filling increases, the ratio of real to complex
fit error standard deviation approaches unity, with a plateau at a zero-filling
factor of √2 and a lack of statistical significance following a zero-filling
factor of 1.026 (Figure 2A). No significant differences in average percent
error were observed. Changes in complex fit results with zero filling were not
observed (Figure 2B).
For metabolite spectra without a baseline and without zero filling, complex
fitting provides a consistently lower error standard deviation, with SNR- and
metabolite-dependent variations in the degree of improvement (Figure 3). With
increasing zero filling, the ratio of standard deviation approaches unity, with
a plateau at a zero-filling factor of 2 and a lack of statistical significance with
zero filling exceeding a factor of √2. Without zero filling, complex fitting
provides an average percent error closer to zero for all but 1 (total-choline, tCho,
at SNR 10) statistical difference. Statistical differences in average are no
longer apparent with zero filling exceeding a factor of √2.
When considering baselines, differences between real and complex fitting vary heavily
by metabolite, with maximal effects in myoinositol (mIns) (whose error standard
deviation favors complex fitting) and glutamate plus glutamine (Glx) (whose error
average favors real fitting) (Figure 4). This remains consistent across zero-filling
conditions. For tCho and mIns, real fitting consistently provides more extreme
estimates across zero-filling conditions.Conclusions
We demonstrate that without zero filling, complex relative to
real fitting consistently provides lower standard deviation and average percent
error, improving precision and accuracy in a metabolite- and SNR-dependent
manner.
As zero filling is applied, the differences in precision and accuracy between
real and complex fitting are attenuated, with a consistent plateau achieved around
a zero-filling factor of √2. However, when considering spectra with in vivo
baselines, zero filling does not inevitably reduce differences observed between
real and complex fitting.
Altogether, although zero filling may theoretically recuperate improvements in
accuracy and precision provided by complex fitting without zero filling, the
presence of physiological baselines may provide confounding factors in the fit
that make the application of zero filling largely ineffective. In addition,
zero filling has been previously shown to complicate the calculation of
Cramér-Rao Lower Bounds19. Further investigation is needed for
generalization of these effects, including examination of additional baselines
and baseline modeling methods. Acknowledgements
This work was performed at the Zuckerman Mind Brain Behavior
Institute MRI Platform, a shared resource. In vivo measurements were derived
from research conducted in accordance with Columbia University Institutional
Review Board protocol AAAQ9641.References
1. Near J, Harris AD, Juchem C, Kreis R, Marjańska M,
Öz G, Slotboom J, Wilson M, and Gasparovic C. Preprocessing, analysis and
quantification in single-voxel magnetic resonance spectroscopy: Experts'
consensus recommendations. NMR in Biomedicine 34 (5) (2021).
2. Mierisova S and Ala-Korpela M. MR spectroscopy
quantitation: A review of frequency domain methods. NMR in Biomedicine
14:247–259 (2001).
3. Zöllner HJ, Povazan M, Hui SCN, Tapper S, Edden
RAE, and Oeltzschner G. Comparison of different linear-combination modeling
algorithms for short-TE proton spectra. NMR in Biomedicine 34(4) (2021).
4. Provencher SW. Estimation of metabolite
concentrations from localized in vivo proton NMR spectra. Magnetic Resonance
in Medicine 30:672-679 (1993).
5. Provencher SW. LCModel & LCMgui User’s Manual
2021.
6. Swanberg KM, Landheer K, Pitt D, and Juchem C.
Quantifying the metabolic signature of multiple sclerosis by in vivo proton
magnetic resonance spectroscopy: Current challenges and future outlook in the
translation from proton signal to diagnostic biomarker. Frontiers in
Neurology 10 (1173) (2019).
7. Campos LC, Swanberg KM, Gajdošík M, Landheer K, and
Juchem C. Complex fitting of 1H-MR spectra improves quantification precision
independent of SNR and noise correlation. Proc Int Soc Magn Reson Med
0430 (2022).
8. R. R. Ernst and E. Bartholdi. Fourier Spectroscopy
and the Causality Principle," Journal of Magnetic Resonance 11:
9-19 (1973).
9. Landheer K and Juchem C. The effects of
cutting/zero-filling and linebroadening on quantification of magnetic resonance
spectra via maximum-likelihood estimation. Proc Int Soc Magn Reson Med
2834 (2021).
10. Manohar SM, Oeltzschner G, Barker PB, and Edden
RAE. The value of zero filling in in vivo MRS. bioRxiv 93:1-2 (2022).
11. Gajdošík M, Landheer K, Swanberg KM, and Juchem C.
INSPECTOR: Free software for magnetic resonance spectroscopy data Inspection,
processing, simulation and analysis. Scientific Reports 11, 2094 (2021).
12. Swanberg KM, Prinsen H, and Juchem C. Spectral
quality differentially affects apparent concentrations of individual
metabolites as estimated by linear combination modeling of in vivo MR
spectroscopy data at 7 Tesla. Proc Int Soc Magn Reson Med 4327 (2019).
13. Swanberg KM, Landheer K, Gajdošík M, Treacy MS,
and Juchem C. Hunting the perfect spline: Baseline handling for accurate macromolecule
estimation and metabolite quantification by in vivo 1H MRS. Proc Int Soc
Magn Reson Med 2856 (2020).
14. Landheer K, Swanberg KM, and Juchem C. Magnetic
resonance Spectrum simulator (MARSS), a novel software package for fast and
computationally efficient basis set simulation. NMR in Biomedicine 34
(2021).
15. Landheer K, Gajdosik M, and Juchem C. A
semi-LASER, single-voxel spectroscopic sequence with a minimal echo time of
20.1 ms in the human brain at 3 T. NMR in Biomedicine 33 (2020).
16. Landheer K, Gajdošík M, Treacy M, Juchem C.
Concentration and effective T2 relaxation times of macromolecules at 3T. Magnetic
Resonance in Medicine 84(5):2327-2337 (2020).
17. Swanberg KM, Gajdošík M, Landheer K, and Juchem C.
Computation of Cramér-Rao Lower Bounds (CRLB) for spectral baseline shapes. Proc
Int Soc Magn Reson Med 2010 (2021).
18. R Core Team (2021). R: A language and environment
for statistical computing. R Foundation for Statistical Computing, Vienna,
Austria. URL https://www.R-project.org/. version 4.1.2.
19. Landheer K, Juchem C. Are Cramer-Rao lower bounds
an accurate estimate for standard deviations in in vivo magnetic resonance
spectroscopy? NMR in Biomedicine (34) (2021).